ShortageWatch RxUS drug shortage tracker, built on FDA data

← All shortages

Iron Sucrose Injection shortage

To Be Discontinued  1 presentations · 1 manufacturers · first FDA posting 2026-05-21 · last update 2026-05-21

Manufacturers: Mylan Institutional, a Viatris Company

Stated reasons (per FDA): Not stated

📬 Get weekly shortage updates by email

Presentations

PresentationManufacturerStatusReasonNotes (FDA)Dates
Iron Sucrose, Injection, 50 mg/2.5 mL (NDC 67457-957-99)Mylan Institutional, a Viatris CompanyTo Be Discontinued
 —A business decision has been made to discontinue of 2.5mL presentation only. Continuity of supply is forecasted across all other presentations of Iron Sucrose: 67457-639-10 Iron Sucrose 20mg/mL 10mL SDV 5PK 67457-638-10 Iron Sucrose 20mg/mL 5mL SDV 10PK 67457-638-25 Iron Sucrose 20mg/mL 5mL SDV 25PK.Posted 05/21/2026
Updated 05/21/2026
Discontinued 05/21/2026

Source: FDA Drug Shortages Database · raw openFDA records

Get the weekly shortage roundup: a free email of FDA shortage changes (open form)